Literature DB >> 6976183

T-cell subpopulations in multiple myeloma: correlation with clinical disease status.

M M Oken, N E Kay.   

Abstract

T-lymphocyte subpopulations bearing Fc receptors for IgM (T mu) or for IgG (T gamma) were studied in blood specimens obtained from 40 normal volunteers and from 16 patients with multiple myeloma. The myeloma patients showed a significant imbalance in T-cell subpopulations characterized by an increase in the percentages of T gamma cells to 30.0 +/- 3.9% (mean +/- SEM) compared with 12.0 +/- 3.0% for the controls (P less than 0.001). The patients exhibited a decreased proportion of T mu cells (13.4 +/- 4.1%) compared with the control value of 55 +/- 7% (P less than 0.001). When the results were analysed according to clinical status it was the patients with indolent or well-controlled disease and not those with progressive disease who exhibited an elevated proportion of T gamma cells. The elevation of T gamma cells or of a subpopulation of suppressor cells should be further studied as a possible mechanism of disease control in multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6976183     DOI: 10.1111/j.1365-2141.1981.tb07273.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; H J Hansen; J R Redman; S Berenson; B J Lee; B D Clarkson
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

Review 2.  Characteristics and function of Fc receptors on human lymphocytes.

Authors:  P M Lydyard; M W Fanger
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

3.  Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.

Authors:  M Gobbi; F Caligaris-Cappio; D Campana; P L Tazzari; L Bergui; M Cavo; S Tura
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

4.  Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.

Authors:  F Lauria; R Foa; M Cavo; M Gobbi; D Raspadori; M C Giubellino; P L Tazzari; S Tura
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Patterns of T cell subset alterations in myelo- and lymphoproliferative disorders.

Authors:  G Fiorini; A Geniram; G Frezzini; S Eridani
Journal:  Blut       Date:  1984-05

6.  Effect of chemotherapy on T-lymphocyte subsets in B-cell proliferative disorders.

Authors:  C A Emmendörffer; W J Pichler
Journal:  Blut       Date:  1985-03

7.  Surface markers and cytotoxic activities of lymphocytes in monoclonal gammopathy of undetermined significance and untreated multiple myeloma. Increased phytohemagglutinin-induced cellular cytotoxicity and inverted helper/suppressor cell ratio are features common to both diseases.

Authors:  G De Rossi; G De Sanctis; V Bottari; M Tribalto; M Lopez; M T Petrucci; L Fontana
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Production of interleukin 2 in multiple myeloma.

Authors:  T Commes; B Klein; M Jourdan; R Bataille
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

9.  Correlation of Fc gamma receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer.

Authors:  D Ilfeld; J Barzilay; Z Dux; M Ran
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 10.  Multiple myeloma presenting with Hemophilus influenzae septic arthritis: case report and review of the literature.

Authors:  V Berthaud; J Milder; W el-Sadr
Journal:  J Natl Med Assoc       Date:  1993-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.